Fierce Pharma characterizes AZ's CEO Pascal Soriot as bristling to the idea that executive pay (including his own) should be tied to the sales forecast that he and board chairman Leif Johansson tossed out there as they tried to fend off Pfizer's takeover bid. At least they were successful with the latter for now (see us again in November).
However, if you are going to tell sales fairy stories, I don't think it is unreasonable for shareholders to ask that your bonus depends on making them true. Afterall, YOU told us to turn down Pfizer's bird in the hand for AZ's fantastic sales in the bush. Careful what you wish for or in this case STATE!
Posted by Bruce Lehr June 2nd 2014.